InspireMD (NSPR) Reports Q4 Loss of $0.31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
InspireMD Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015
March 28, 2016 8:27 AM EDTBOSTON, MA -- (Marketwired) -- 03/28/16 -- InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced its financial and operating results for the fourth quarter and year ended December 31, 2015.
In 2015, InspireMD advanced its strategic transition into the carotid and neuro interventional markets utilizing its proprietary MicroNet" technology. Key activities include announced:
Consistent, positive clinical results, with therapeutic benefits sustained at 12 months from the CGuard" CARENET trial, as well... More